
On November 20, the US Commerce Department issued an affirmative preliminary anti-dumping determination on Tris (tromethamine) from China, with dumping margins of 9.07% to 129.46% for three named exporters and a 132.59% national rate for others. A countervailing duty preliminary ruling was issued in September, and final determinations are expected in early February 2027.
This concerns a biochemical buffer used in pharmaceuticals and diagnostics, not a feed input, so it has no meaningful effect on feed supply, demand or prices.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.